⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL6404922 | 0.97 | — | — | |
| Methylene Chloride SCHEMBL28623150 | 0.91 | TRPA1 (0.38) | — | |
| SCHEMBL9792803 | 0.78 | — | — | |
| SCHEMBL13559062 | 0.78 | — | — | |
| SCHEMBL24074651 | 0.77 | CYP1A2 (0.38) | — | |
| SCHEMBL20078924 | 0.75 | — | — | |
| SCHEMBL4263880 | 0.75 | — | — | |
| SCHEMBL6404918 | 0.75 | — | — | |
| SCHEMBL6577704 | 0.73 | — | — | |
| SCHEMBL8407864 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1030 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026107377-A1 | PHARMACOLOGICAL RE-ACTIVATION OF MUTANT PVHL | KARANICOLAS JOHN (US) | 2026-05-21 | — | — | WO | disclosed |
| US-20260125359-A1 | HETEROARYL COMPOUNDS AS MULTI-TARGET PROTEIN KINASE INHIBITORS | FUJIAN HAIXI PHARMACEUTICALS CO LTD (CN) | 2026-05-07 | — | — | US | disclosed |
| US-12617785-B2 | Pyrrolo[2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss | THE ROCKEFELLER UNIVERSITY (US) | 2026-05-05 | — | — | US | disclosed |
| EP-4711368-A1 | AZEPINE COMPOUND, AND COMPOSITION AND USE THEREOF | CHENGDU MFS PHARMA. CO., LTD. (CN) | 2026-03-18 | — | — | EP | disclosed |
| US-20260048045-A1 | PI3K-ALPHA INHIBITORS FOR THE TREATMENT OF CANCER | SCORPION THERAPEUTICS INC (US) | 2026-02-19 | — | — | US | disclosed |
| EP-4334298-B1 | UREA DERIVATIVES WHICH CAN BE USED TO TREAT CANCER | SCORPION THERAPEUTICS INC (US) | 2026-02-18 | — | — | EP | disclosed |
| US-20260041672-A1 | Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators, Pharmaceutical Compositions, and Uses Thereof | UNIV EMORY (US) | 2026-02-12 | — | — | US | disclosed |
| CN-121226193-A | Trifluoro-methoxy method for synthesizing wei | 江苏海洋大学 | 2025-12-30 | — | — | CN | disclosed |
| US-12503477-B2 | Colony stimulating factor-1 receptor (CSF-1R) inhibitors | GENZYME CORPORATION | 2025-12-23 | — | — | US | disclosed |
| US-12473295-B2 | Substituted straight chain spiro derivatives | JANSSEN PHARMACEUTICA NV (BE) | 2025-11-18 | — | — | US | disclosed |
| US-4584373-A | MICROBIOCIDES, FUNGICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1986-04-22 | — | — | US | disclosed |
| US-4535081-A | Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor | PFIZER INC. (US) | 1985-08-13 | — | — | US | disclosed |
| US-4514566-A | INSECTICIDES, MOLLUSCICIDES, MITICIDES AND NEMATOCIDES | HOFFMANN-LA ROCHE INC. (US) | 1985-04-30 | — | — | US | disclosed |
| EP-0131867-A2 | Aryloxy-pyrimidinyl alkanols | BAYER AG (DE) | 1985-01-23 | — | — | EP | disclosed |
| US-4427687-A | INSECTICIDES, MITICIDES, AND MOLLUSCICIDES | HOFFMANN-LA ROCHE INC. (US) | 1984-01-24 | — | — | US | disclosed |
| US-4423048-A | Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor | PFIZER INC. (US) | 1983-12-27 | — | — | US | disclosed |
| US-4414388-A | ANTIALLERGENS, ANTIULCER AGENTS | PFIZER INC. (US) | 1983-11-08 | — | — | US | disclosed |
| US-4321372-A | Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides | PFIZER INC. (US) | 1982-03-23 | — | — | US | disclosed |
| EP-0039520-A1 | Carbamoyl oximes, processes and intermediates for their preparation, pesticides containing them and use of these compounds as pesticides | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-11-11 | — | — | EP | disclosed |
| US-4240983-A | HALOGENATION | BAYER AKTIENGESELLSCHAFT (DE) | 1980-12-23 | — | — | US | disclosed |